Brokerages Set Healthequity Inc (HQY) Target Price at $57.50

Healthequity Inc (NASDAQ:HQY) has been assigned an average recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among brokers that have covered the stock in the last year is $57.50.

HQY has been the topic of several analyst reports. BidaskClub upgraded Healthequity from a “sell” rating to a “hold” rating in a report on Friday, December 22nd. Zacks Investment Research cut Healthequity from a “buy” rating to a “hold” rating and set a $62.00 target price on the stock. in a report on Tuesday, February 27th. Citigroup assumed coverage on Healthequity in a report on Thursday, January 4th. They issued a “buy” rating on the stock. Cantor Fitzgerald reissued a “buy” rating and issued a $56.00 price target on shares of Healthequity in a research note on Tuesday, December 5th. Finally, JPMorgan Chase & Co. dropped their price target on Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 24th.

How to Become a New Pot Stock Millionaire

In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $47.91, for a total value of $455,145.00. Following the transaction, the vice president now directly owns 96,500 shares of the company’s stock, valued at $4,623,315. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Jon Kessler sold 40,000 shares of the business’s stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $49.47, for a total value of $1,978,800.00. Following the completion of the transaction, the insider now directly owns 485,000 shares in the company, valued at $23,992,950. The disclosure for this sale can be found here. Over the last three months, insiders sold 661,732 shares of company stock worth $34,493,276. Insiders own 29.00% of the company’s stock.

Several large investors have recently modified their holdings of the company. Grandeur Peak Global Advisors LLC raised its position in shares of Healthequity by 151.4% during the fourth quarter. Grandeur Peak Global Advisors LLC now owns 25,325 shares of the company’s stock worth $1,182,000 after purchasing an additional 15,250 shares during the period. Xact Kapitalforvaltning AB acquired a new position in shares of Healthequity during the fourth quarter worth approximately $220,000. Westover Capital Advisors LLC acquired a new position in shares of Healthequity during the fourth quarter worth approximately $702,000. MetLife Investment Advisors LLC acquired a new position in shares of Healthequity during the fourth quarter worth approximately $1,090,000. Finally, Two Sigma Securities LLC acquired a new position in shares of Healthequity during the fourth quarter worth approximately $208,000. 99.63% of the stock is currently owned by institutional investors.

Shares of Healthequity (NASDAQ HQY) traded up $0.16 during mid-day trading on Wednesday, reaching $59.39. The company had a trading volume of 749,927 shares, compared to its average volume of 700,060. Healthequity has a 1-year low of $37.62 and a 1-year high of $60.00. The company has a market capitalization of $3,593.64, a PE ratio of 80.26, a PEG ratio of 2.26 and a beta of 1.46.

TRADEMARK VIOLATION WARNING: “Brokerages Set Healthequity Inc (HQY) Target Price at $57.50” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/09/brokerages-set-healthequity-inc-hqy-target-price-at-57-50.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply